Join HSANZ
In 2020, the Haemovigilance Advisory Committee (HAC) proposed to host a series of online forums on current issues in Haemovigilance, with both Australian and international speakers. The National Blood Authority (NBA) established a working group, and they developed a draft program for a series of four free, open-access, 90-minute online forums.
The Australian and New Zealand Society of Blood Transfusion (ANZSBT), International Haemovigilance Network (IHN) and International Society of Blood Transfusion (ISBT) agreed to collaborate with the NBA, and with ISBT hosting the forums via their existing webinar platform.
Flyer here
Registration for each webinar is now available on the ISBT website at Haemovigilance Webinars: Haemovigilance in Australia and Beyond | The International Society of Blood Transfusion (ISBT) (isbtweb.org). The webinars are also advertised on the NBA website at Haemovigilance | National Blood Authority
Did you know there is an HSANZ Advanced Trainee Workshop as part of Blood2022 on Saturday 10th September
To attend the HSANZ Advanced Trainee Workshop, you must meet criteria;
Support for Interstate Attendees
Attendees who meet the criteria above and are attending from outside NSW and are not receiving travel assistance from any other sources may apply for support for economy flights and/or 1 nights’ accommodation (Friday 9th September).
In order to be considered for this support, you must complete registration and indicate your need for support. Once eligibility has been confirmed, the organisers will contact you in regards to your flight and accommodation bookings.
If you are not a member, join NOW www.hsanz.org.au and click APPLY
From Patient Blood Management National Blood Authority:
Public Consultation Open – Single Unit Transfusion Flowchart
The draft Single Unit Transfusion Flowchart has been developed by an expert working group and the National Blood Authority (NBA) as a decision support tool designed to assist clinicians with appropriate prescribing of red blood cells. The International Society for Blood Transfusion defines single unit transfusion as “in the non-bleeding patient, single-unit transfusion refers to a standard dosing scheme of one unit of red blood cells, followed by an assessment of the patient’s signs and symptoms to determine whether additional units are indicated.”
A single unit transfusion policy can ensure the safety and efficacy of red blood cell transfusion by confirming every unit transfused is a clinical decision where the expected benefit outweighs the risks.
Implementing a single unit transfusion policy will help hospitals meet the National Safety and Quality Health Service Blood Management Standard. The Single Unit Transfusion Flow Chart will be available for download from the NBA website once finalised.
The National Blood Authority invite interested individuals, groups and organisations to comment on the Flowchart and encourage you to advise your colleagues of its availability for public comment. The Flowchart will not be mandatory but available as a tool for Australian health providers implementing a single unit transfusion policy.
The draft Flowchart and comments template are available on the NBA’s website at: http://www.blood.gov.au/public-consultation
The closing date for submissions is 5pm Friday 5 August 2022.
HSANZ and a number of other societies have been lobbying for the reimbursement of NGS for myeloproliferative neoplasm. I’m pleased to say that this has been approved for ET/ PV (item 73398) and transplant eligible myelofibrosis (item 73399). Please contact your friendly haematopathology service for details about testing and availability.
Best wishes Steven Lane – on behalf HSANZ
The second Australasian COVID-19 Conference will be held in Sydney at the
Sheraton Grand Sydney Hyde Park on 21-22 July 2022
For full information: https://www.covid-19conference.com.au/
The Malaysian Society of Haematology, have asked us to inform you that they will be hosting the 19th Annual Scientific Meeting 2022virtually at https://mshaema.com/ from the 9 to 11 August 2022.
The theme of the virtual meeting is Cell Based Therapies: The New Frontier In Personalized And Targeted Therapy. This theme was chosen specifically to focus on sharing the latest developments in the field of Cell Therapy. After 2 years of lockdown where everyone has been rightly focused on COVID-19, it is now time for recovery and to shine the spotlight on the developments that have quietly taken place in the field.
To register: https://mshaema.com/registration
Authors will be notified of the outcome of the review process at the end of July.
We look forward to welcoming you to the BLOOD Scientific Meeting 2022 in September.
www.blood2022.com
NHMRC Centre for Blood Transplant and Cell Therapies Webinar 30 May 2022
The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. This webinar features Professor Nicolaus Kroger, who is the Medical Director of the Department of Stem Cell Transplantation and Professor of Medicine at the University Medical Center in Hamburg-Eppendorf, Germany. Since 2018, he has served as the President of the European Society of Blood and Marrow Transplantation (EBMT), and the a co-editor of the EBMT Handbook and the EBMT/EHA CAR-T cell Handbook. From 2014 – 2020 he was the chairman of the German Stem Cell Working Group, and is an active member of several Scientific Committees such as ASH, EHA and ESH. Professor Kroger has published extensively in his area of expertise and contributed to more than 750 publications. In this webinar, Professor Kroger will be comparing the roles of haploidentical and matched unrelated donor stem cell transplantation in acute myeloid leukaemia.
Speaker:
Professor Nicolaus Kroger – University Medical Center, Hamburg-Eppendorf
When: Monday 30 May 2022, 5pm AEST
Brochure with full information here
Link to webinar:
Link to CBTCT website for all webinar recordings:
A reminder there's only one week to go until submissions for BLOOD 2022 close on Wednesday 18 May 2022. Don’t miss out on making a contribution to the Meeting and presenting your work to peers in the wide field of blood sciences across Australia and New Zealand. You have until 8pm AEST Wednesday 18 May 2022 to submit your abstract.
A variety of awards and travel grants are also available. To ensure you are eligible, view the criteria for these awards here
On behalf of the 2022 Local Organising Committee
© 2023 Haematology Society of Australia & New Zealand All Rights Reserved.
Privacy Policy
